carvedilol has been researched along with Heart Failure, Diastolic in 4 studies
Heart Failure, Diastolic: Heart failure caused by abnormal myocardial relaxation during DIASTOLE leading to defective cardiac filling.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The Japanese Diastolic Heart Failure Study (J-DHF) is a multicentre, prospective, randomized, open, blinded-endpoint trial, designed to assess the effects of carvedilol in HFPEF patients." | 9.17 | Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF). ( Hori, M; Origasa, H; Yamamoto, K, 2013) |
| "The Japanese Diastolic Heart Failure Study (J-DHF) has suggested beneficial effects of the standard-dose prescription of carvedilol in heart failure with preserved ejection fraction (HFPEF)." | 7.80 | Relation of risk factors with response to carvedilol in heart failure with preserved ejection fraction - a report from the Japanese Diastolic Heart Failure Study (J-DHF). ( Hori, M; Izumi, C; Origasa, H; Sakata, Y; Shinozaki, T; Suzuki, Y; Taira, K; Takahashi, T; Watanabe, T; Yamamoto, K, 2014) |
| " The Japanese Diastolic Heart Failure Study (J-DHF) is a multicentre, prospective, randomized, open, blinded-endpoint trial, designed to assess the effects of carvedilol in HFPEF patients." | 5.17 | Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF). ( Hori, M; Origasa, H; Yamamoto, K, 2013) |
| "Therapeutic efficiency of spirapryl and its combination with carvedilol in the treatment of diastolic cardiac insufficiency in patients with type 2 diabetes and essential arterial hypertension (AH)." | 5.14 | [Drug therapy of diastolic cardiac insufficiency in patients with type 2 diabetes and concomitant essential arterial hypertension]. ( Borovkov, NN; Iarkova, NA, 2009) |
| "The Japanese Diastolic Heart Failure Study (J-DHF) has suggested beneficial effects of the standard-dose prescription of carvedilol in heart failure with preserved ejection fraction (HFPEF)." | 3.80 | Relation of risk factors with response to carvedilol in heart failure with preserved ejection fraction - a report from the Japanese Diastolic Heart Failure Study (J-DHF). ( Hori, M; Izumi, C; Origasa, H; Sakata, Y; Shinozaki, T; Suzuki, Y; Taira, K; Takahashi, T; Watanabe, T; Yamamoto, K, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, K | 2 |
| Origasa, H | 2 |
| Suzuki, Y | 1 |
| Takahashi, T | 1 |
| Shinozaki, T | 1 |
| Watanabe, T | 1 |
| Sakata, Y | 1 |
| Izumi, C | 1 |
| Taira, K | 1 |
| Hori, M | 2 |
| Iarkova, NA | 1 |
| Borovkov, NN | 1 |
| Wong, DT | 1 |
| Clark, RA | 1 |
| Dundon, BK | 1 |
| Philpott, A | 1 |
| Molaee, P | 1 |
| Shakib, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Clinical Trial of Radiofrequency Ablation for Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction for Reduced Healthcare Utilization[NCT04327596] | 2 participants (Actual) | Interventional | 2021-01-25 | Terminated (stopped due to lack of enrollment) | |||
| Mechanisms and Management of Exercise Intolerance in Older Heart Failure Patients With Preserved Ejection Fraction[NCT03111017] | 12 participants (Actual) | Interventional | 2017-04-17 | Completed | |||
| Slow-release CArvedilol in Patients With REduced Strain and Preserved Ejection Fraction Heart Failure (CARE-preserved HF): A Prospective Randomized, Double-Blinded, Multicenter Study[NCT05553314] | Phase 4 | 100 participants (Anticipated) | Interventional | 2021-11-17 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for carvedilol and Heart Failure, Diastolic
| Article | Year |
|---|---|
[Drug therapy of diastolic cardiac insufficiency in patients with type 2 diabetes and concomitant essential arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; B | 2009 |
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbazoles; Carvedilol; Female; Follow-Up Studies; He | 2013 |
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbazoles; Carvedilol; Female; Follow-Up Studies; He | 2013 |
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbazoles; Carvedilol; Female; Follow-Up Studies; He | 2013 |
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbazoles; Carvedilol; Female; Follow-Up Studies; He | 2013 |
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbazoles; Carvedilol; Female; Follow-Up Studies; He | 2013 |
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbazoles; Carvedilol; Female; Follow-Up Studies; He | 2013 |
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbazoles; Carvedilol; Female; Follow-Up Studies; He | 2013 |
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbazoles; Carvedilol; Female; Follow-Up Studies; He | 2013 |
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Carbazoles; Carvedilol; Female; Follow-Up Studies; He | 2013 |
2 other studies available for carvedilol and Heart Failure, Diastolic
| Article | Year |
|---|---|
Relation of risk factors with response to carvedilol in heart failure with preserved ejection fraction - a report from the Japanese Diastolic Heart Failure Study (J-DHF).
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Body Mass Index; Carbazoles; Carvedilol; Diabe | 2014 |
Caveat anicula! Beware of quiet little old ladies: demographic features, pharmacotherapy, readmissions and survival in a 10-year cohort of patients with heart failure and preserved systolic function.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihyperte | 2010 |